Our News Library | Levin Papantonio - Personal Injury Lawyers

California Wildfires Appear to be a Year-Round Danger. Meanwhile, PG&E Seeks Bankruptcy “Protection”

Global climate change has begun a vicious cycle in California. What was once a seasonal hazard is now 12 months a year, according to a report published earlier this month in Bloomberg. Because of warming, large areas of the Golden State have been “riddled with pockets of dry bush” and nearly 130 million trees have died. As a result, wildfire danger is now constant, not just during summer and early fall.

read more

National Safety Council: Opioid Overdose Deaths Now Exceed Traffic Fatalities

For the first time in U.S. history, the risk of dying from an opioid overdose is greater than that of being killed in a traffic accident. Opioids also exceed slip and fall incidents, drowning, and fire as causes of unintentional deaths. Furthermore, only 13 states (including the District of Columbia) are making any progress in dealing with the crisis.

read more

Yet Another Sartan Drug Recalled Due to Carcinogens

Aurobindo Pharma USA, Inc. has issued a voluntary recall of three of its sartan-based prescription medications after discovering trace amounts of a carcinogenic substance known as N-nitrosodiethylamine (NDEA). The recall, which the FDA announced on Dec. 31st, affects a total of 80 lots of Valsartan, Amlodipine Valsartan, and Valsartan HCTZ pills with expiration dates between May 2019 and March 2021.

read more

The Psychological Impacts of Taxotere Hair Loss

One of the challenges when it comes to determining damages in injury lawsuits is putting a monetary value on intangible losses, such as pain and suffering, emotional distress, and anxiety. These are considered to be “non-economic damages,” and fall under the category of “mental anguish.” Putting a dollar figure on emotional pain is difficult, but it is nonetheless a factor that can diminish the quality of life as surely as a crippling injury.

read more

A New IVC Filter is Successfully Implanted in Patients: Will it be an Improvement?

After two years of clinical trials, a new type of IVC filter was recently implanted in a number of patients under “real world” conditions in an Arizona hospital.  The product is called the “Sentry” and is produced by BTG Interventional Medicine, a company based in the UK.

Introduced this month at Vascular Interventional Advances Conference in Las Vegas, the new IVC filter has what the manufacturer describes as a “unique bioconversion feature”, making retrieval of the device unnecessary.

read more

A Third Sartan Drug is Found to Contain NDEA

For the second time in as many weeks, the Food and Drug Administration has notified physicians and patients that yet another sartan drug used to treat hypertension has been contaminated with a carcinogenic industrial chemical. The manufacturer of the drug has issued a voluntary recall for a single lot of the medication losartan (potassium hydrochlorothiazide), identified as JB8912.

read more

Proton Pump Inhibitors and Iron Deficiency

Australian researchers recently published a study that has found a link between the use of proton pump inhibitors (PPIs) and iron deficiency. When iron levels in the body are insufficient, it can lead to anemia, a condition in which the amount of hemoglobin (red blood cells) decline to dangerously low levels. Untreated, anemia puts excess strain on the heart muscle, causing a lack of oxygen and leading to serious organ damage. In extreme cases, it can be fatal.

read more

$19 Million Award in UBS Puerto Rico Bond Fraud Arbitration

Levin Papantonio Thomas Mitchell Rafferty & Proctor P.A. of Pensacola, Florida, one of the nation’s preeminent Plaintiffs law firms, announced today that it has won a verdict along with John F. Nevares & Associates of Santurce, Puerto Rico, in a FINRA Arbitration against UBS Financial Services Inc. (UBS) and UBS Financial Services Inc. of Puerto Rico (UBS-PR). The verdict, for total damages in excess of $19 million, was obtained on behalf of their client in FINRA Arbitration # 15-01833.

read more

Otsuka Off the Hook for Deleted Emails in Abilify Litigation

In a recent decision by a Florida federal judge, Abilify maker Otsuka Pharmaceuticals was absolved of responsibility to preserve company e-mails that might have served as evidence for plaintiffs in current Abilify litigation.  The reason: the emails were written years ago, long before the company could reasonably have anticipated having to defend itself against lawsuits.

read more